Clinical Trial Update: GSK706769/KALETRA Drug-drug Interaction Study [Phase 1]

View source ↗

Summary

Phase 1 drug-drug interaction study between GSK706769 and KALETRA (lopinavir/ritonavir) has been completed. The study investigated potential interactions in HIV…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• GSK706769
• Kaletra (lopinavir)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED